Just as effective as the high dose, low-dose apixaban prevents long-term recurrent venous thromboembolism in patients with ...
Christian T. Ruff, MD, MPH, of Brigham and Women's Faulkner Hospital, discusses new data comparing abelacimab with ...
A trial is set to begin for seven medics accused of negligence in their treatment of Argentine footballing icon Diego Maradona, who died in 2020. Maradona, regarded as one of the greatest ...
MONTREAL — Quebec’s highest court says it will hear Just for Laughs founder Gilbert Rozon’s appeal over a decision that limited the questions his defence could ask during his civil trial for sexual ...
In this atmosphere, the trial for the death of Diego Armando Maradona began on Tuesday, after two suspensions and more than four years since his passing. The process seeks to determine whether a ...
As the trial of missing six-year-old Joshlin Smith enters its seventh day, new witnesses from the Saldanha Bay community are set to testify about their experiences following her disappearance.
Produced by ElevenLabs and News Over Audio (Noa) using AI narration. Listen to more stories on the Noa app. Khalil, a legal permanent resident of the United States and Palestinian activist who ...
Visma-Lease a Bike powered to victory in the stage 3 team time trial in Paris-Nice, moving defending champion Matteo Jorgenson into the yellow jersey. The Dutch team beat Jayco-AlUla by 14 seconds ...
An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet, external medical journal.
Shares in Novo Nordisk fell on Monday on a second set of worse than expected trial results for the latest obesity drug from the manufacturer of blockbuster treatments Ozempic and Wegovy.
While clinical trials establish the safety and efficacy of new therapies, real-world data help bridge the gap between these highly controlled environments and patient care in the real world.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results